透景生命：武汉康录生物技术股份有限公司自2025年8月31日起纳入公司的合并报表范围

Group 1 - The core point of the article is that Tsinghua Unigroup's subsidiary, Wuhan Kanglu Biotechnology Co., Ltd., will be included in the consolidated financial statements of Tsinghua Unigroup starting from August 31, 2025, and its performance will be reflected in the third quarter of 2025 based on data from September only [1] - The current performance of Wuhan Kanglu Biotechnology is in line with the promised net profit [1]